Navigation Links
Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society's Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
Date:11/4/2008

JERUSALEM, November 4 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of proprietary drug delivery systems, announced today that its poster entitled "Enteral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in Dogs," has been accepted for presentation at the Diabetes Technology Society's Eighth Annual Meeting in Bethesda, Maryland between November 13-15, 2008.

Oramed's exploratory study of enteral delivery of GLP-1 analog, exenatide-4, an incretin mimetic with antihyperglycemic actions on dogs, advances research in the area of enteral delivery of polypeptides and proteins. Oramed's test results showed that direct instillation of GLP-1 analog significantly curbed post-glucose loading, demonstrating the feasibility of administering the drug enterally.

"The selection of Oramed as one of the companies to present at the Diabetes Technology Conference is a wonderful opportunity for us to demonstrate our revolutionary technology to the world's leading diabetes scientists," said Nadav Kidron, Oramed CEO. "We are very proud that our research is advancing the treatment of diabetes and we look forward to continuing to present strong results from the studies and trials we are currently conducting."

Oramed's abstract will be presented on Thursday, November 13, from 6-8 PM. The poster will be available for viewing throughout the conference.

For more information about the Diabetes Technology Society's Eighth Annual Meeting, please visit http://www.diabetestechnology.org/index.html

For more information about Oramed Pharmaceuticals, please visit http//www.oramed.com

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via
'/>"/>

SOURCE Oramed Pharmaceticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
2. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
3. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
4. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
5. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
6. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
7. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
8. Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
9. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
10. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
11. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...H,Texas,Nov.23/PRNewswire-FirstCall/--WoundManagem...lygrowingproviderofspecialtymedicalproducts,announ...videdacomprehensivemanagementbusinessupdatetoillus..., Q32009salesincreased33.5%to$102,926vs.Q32008sa...9increasedto$3,327,892vs.Q32008shareholderequityof...
(Date:11/23/2009)...,Nov.23/PRNewswire-FirstCall/--CordBloodAmerica,In...mcellpreservationcompany( http://www.cordblood-ame...fstemcells,abiologicalinsurancepolicy,tofamiliesna...atedprogressinterviewwithCEOandco-founderMatthewSc...t: http://blip.tv/file/2875811 . ,, Intheinterv...
(Date:11/23/2009)...alif.,Nov.23/PRNewswire-FirstCall/--RaptorPharmace...todayannouncedthepresentationofclinicaltrialdataon...MPA/kainatereceptorantagonist,atthe12thInternation...icPain,heldonNovember20-21inSanFrancisco.Theresult...alAnesthesiologyattheCenterforPainMedicineoftheUni...
Breaking Medicine Technology:Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5PA Helping Life Science Companies Secure Venture Capital Needed to Expand Gov Rendell Says 13911 1PA Helping Life Science Companies Secure Venture Capital Needed to Expand Gov Rendell Says 13911 2Injury Research and Health Organizations Urge Congress to Save Lives and Money by Including Injury Prevention in Health Care Reform 56472 1Injury Research and Health Organizations Urge Congress to Save Lives and Money by Including Injury Prevention in Health Care Reform 56472 2Injury Research and Health Organizations Urge Congress to Save Lives and Money by Including Injury Prevention in Health Care Reform 56472 3Its Now or Never Deadline for Olympic Hopeful Skater With Secret Weapon 56470 1Its Now or Never Deadline for Olympic Hopeful Skater With Secret Weapon 56470 2
(Date:11/23/2009)...lf-reported by American surgeons are strongly rela... appear today in the online edition of Annals of ...borators from Johns Hopkins and the American Colle...nearly 9 percent of U.S. surgeons responding said ...to being surveyed. Over 70 percent attributed the ...
(Date:11/23/2009)...ifer Heys wants to make her message clear: there n...bout contraception. , Heys, research, on HIV-po...hildren, was read by experts from all over the wor...ference on Family Planning in Kampala, Uganda. , ... spent six months interviewing 421 people who live...
(Date:11/23/2009)...nnounce its participation in the 2009 CR report co...sible amongst all major CR vendors. iCRco is the o... sales, service and technology fields and scored 1...ality. iCRco is very pleased to have been rated wi...rch firm in medical imaging, KLAS. , ...
(Date:11/23/2009)...portlinker.comannouncesthatanewmarketresearchrepor...ortlinker.com/p0165298/Childrens-Food-and-Drinks-i...ion-2nd-Edition.html#utm_source=prnewswire&utm...pitethegrowingattentionbeingpaidtotheworld,sageing...thatcannotbeoverlooked.Childrenagedbetween5and14re...
(Date:11/23/2009)...harma,Inc.("Victory")announcedtodaythelaunchofNAPR...RELANfranchise. ,, NAPRELANDoseCardisdesignedfo...inflammationassociatedwithprimarydysmenorrheaandac...tssufferingfromrheumatoidarthritisorosteoarthritis...ti-inflammatory/analgesicactivityforalimitedtime.T...
Breaking Medicine News(10 mins):Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:AIDS research reveals a lack of family-planning programs in Uganda 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 3Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 2Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 3Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 4Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 5Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 6Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 7Health News:Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card 2
... Broadlane is pleased to announce its...rld,s largest online marketplace for buying and se... Dallas, TX (PRWEB) January ...lling surplus medical equipment and supplies. , ...
...n. 27 /PRNewswire-FirstCall/ - QLT Inc. ("QLT") (N...y results of its modified "Dutch Auction" tender o...stern time) on January 26, 2009. , Based on the pr...f US$2.50 per Share, for a total cost of US$50 mil...
.... 27 Today, Care to Care announced Barbara Kelman...ficer and Senior Vice President. , , "Following ...Kelman join our team," says Martin Farbenblum, Cha...erspectives. This includes demonstrated excellenc...
...riz., Jan. 27 Prime Companies, Inc. (Pink S...ents: , , , , The Company has begun rec... its new www.mychoicedentist.com web site. , ...ed Prime Companies is moving successfully forwar...
... SnoreMeds snoring mouthpiece is an eff...ered to be an effective device to treat snoring by...ndez. He had suffered for years with snoring and m...09 -- Sleep plays a vital role in our daily lives ...
... A new research study could redefine tr...cago, IL (Vocus) January 27, 2009 -- Americans are...population is at greater risk for acquiring diseas...escribed as "poor circulation," is diagn...
Other Medicine News:Health News:Broadlane Offers Clients Capital Equipment Disposition Alternative through MEDmarketplace.com 2Health News:Broadlane Offers Clients Capital Equipment Disposition Alternative through MEDmarketplace.com 3Health News:Broadlane Offers Clients Capital Equipment Disposition Alternative through MEDmarketplace.com 4Health News:QLT announces preliminary results of tender offer 2Health News:QLT announces preliminary results of tender offer 3Health News:Care to Care Announced Today That Barbara Kelman Has Joined the Organization as Senior Vice President/ Chief Operating Officer 2Health News:Prime Companies Revenue Stream Begins; Dentists in Every City and Town Available on Company's New Web Site 2Health News:Snoring Mouthpiece: Cost effective Solution For Snorers 2Health News:Snoring Mouthpiece: Cost effective Solution For Snorers 3Health News:Tamaris Announces Foot and Leg Ulcers Pose Significant Health Threat 2
SureStep AMP/COC/MAMP/OPI/THC
SureStep Cocaine (COC)
SureStep THC cannabis
BinaxNOW Malaria (5 Tests)
Medicine Products: